Moreover, TFPI2 has been reported to be expressed by vascular endothelial cells, trophoblasts, inflammatory cells, and immune cells, where it exerts multifaceted effects on both the pathological progression and resolution of inflammation-associated diseases such as diabetes, arteriosclerosis, and preeclampsia [15,23,24]. This evidence concerns the gene TFPI2 and diabetes mellitus.